Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)Business Wire • 05/01/24
10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 04/30/24
Down -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a TurnaroundZacks Investment Research • 04/24/24
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene PanelPRNewsWire • 03/21/24
Vizgen Announces Denial of 10x Genomics' Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted Against 10x's Xenium PlatformBusiness Wire • 03/13/24
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024PRNewsWire • 02/15/24
10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseZacks Investment Research • 02/08/24
10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X TechnologyPRNewsWire • 02/07/24
10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General MeetingPRNewsWire • 02/05/24
TXG Alert: Johnson Fistel Announces Investigation of 10x Genomics for Potential Securities Law ViolationsBusiness Wire • 02/01/24
10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024PRNewsWire • 01/24/24
Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor InvasivenessPRNewsWire • 12/19/23